Literature DB >> 15456759

Human PTIP facilitates ATM-mediated activation of p53 and promotes cellular resistance to ionizing radiation.

Paul A Jowsey1, Aidan J Doherty, John Rouse.   

Abstract

Mus musculus Pax2 transactivation domain-interacting protein (Ptip) is an essential gene required for the maintenance of genome stability, although its precise molecular role is unclear. Human PTIP (hPTIP) was recently isolated in a screen for proteins, translated from cDNA pools, capable of interacting with peptides phosphorylated by the ATM (ataxia telangiectasia-mutated)/ATR (ataxia telangiectasia-related) protein kinases. hPTIP was described as a 757-amino acid protein bearing four BRCT domains. Here we report that instead full-length endogenous hPTIP contains 1069 amino acids and six BRCT domains. hPTIP shows increased association with 53BP1 in response to ionizing radiation (IR) but not in response to other DNA-damaging agents. Whereas translocation of both 53BP1 and hPTIP to sites of IR-induced DNA damage occurs independently of ATM, IR-induced association of PTIP and 53BP1 requires ATM. Deletion analysis identified the domains of 53BP1 and hPTIP required for protein-protein interaction and focus formation. Data characterizing the cellular roles of hPTIP are also presented. Small interfering RNA was used to show that hPTIP is required for ATM-mediated phosphorylation of p53 at Ser(15) and for IR-induced up-regulation of the cyclin-dependent kinase inhibitor p21. Lowering hPTIP levels also increased cellular sensitivity to IR, suggesting that this protein plays a critical role in maintaining genome stability.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15456759     DOI: 10.1074/jbc.M411021200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  43 in total

1.  Knockdown of ALR (MLL2) reveals ALR target genes and leads to alterations in cell adhesion and growth.

Authors:  Irina Issaeva; Yulia Zonis; Tanya Rozovskaia; Kira Orlovsky; Carlo M Croce; Tatsuya Nakamura; Alex Mazo; Lea Eisenbach; Eli Canaani
Journal:  Mol Cell Biol       Date:  2006-12-18       Impact factor: 4.272

2.  PTIP associates with MLL3- and MLL4-containing histone H3 lysine 4 methyltransferase complex.

Authors:  Young-Wook Cho; Teresa Hong; Sunhwa Hong; Hong Guo; Hong Yu; Doyeob Kim; Tad Guszczynski; Gregory R Dressler; Terry D Copeland; Markus Kalkum; Kai Ge
Journal:  J Biol Chem       Date:  2007-05-11       Impact factor: 5.157

Review 3.  Control of histone methylation and genome stability by PTIP.

Authors:  Ivan M Muñoz; John Rouse
Journal:  EMBO Rep       Date:  2009-02-20       Impact factor: 8.807

4.  PTIP regulates 53BP1 and SMC1 at the DNA damage sites.

Authors:  Jiaxue Wu; Marc J Prindle; Gregory R Dressler; Xiaochun Yu
Journal:  J Biol Chem       Date:  2009-05-04       Impact factor: 5.157

5.  Smc5/6 maintains stalled replication forks in a recombination-competent conformation.

Authors:  Anja Irmisch; Eleni Ampatzidou; Ken'ichi Mizuno; Matthew J O'Connell; Johanne M Murray
Journal:  EMBO J       Date:  2009-01-21       Impact factor: 11.598

Review 6.  Double-strand break repair: 53BP1 comes into focus.

Authors:  Stephanie Panier; Simon J Boulton
Journal:  Nat Rev Mol Cell Biol       Date:  2013-12-11       Impact factor: 94.444

Review 7.  Role of 53BP1 in the regulation of DNA double-strand break repair pathway choice.

Authors:  Arun Gupta; Clayton R Hunt; Sharmistha Chakraborty; Raj K Pandita; John Yordy; Deepti B Ramnarain; Nobuo Horikoshi; Tej K Pandita
Journal:  Radiat Res       Date:  2013-12-09       Impact factor: 2.841

Review 8.  53BP1: pro choice in DNA repair.

Authors:  Michal Zimmermann; Titia de Lange
Journal:  Trends Cell Biol       Date:  2013-10-04       Impact factor: 20.808

9.  53BP1 promotes ATM activity through direct interactions with the MRN complex.

Authors:  Ji-Hoon Lee; Aaron A Goodarzi; Penny A Jeggo; Tanya T Paull
Journal:  EMBO J       Date:  2009-12-10       Impact factor: 11.598

10.  PAXIP1 Potentiates the Combination of WEE1 Inhibitor AZD1775 and Platinum Agents in Lung Cancer.

Authors:  Ankita Jhuraney; Nicholas T Woods; Gabriela Wright; Lily Rix; Fumi Kinose; Jodi L Kroeger; Elizabeth Remily-Wood; W Douglas Cress; John M Koomen; Stephen G Brantley; Jhanelle E Gray; Eric B Haura; Uwe Rix; Alvaro N Monteiro
Journal:  Mol Cancer Ther       Date:  2016-05-11       Impact factor: 6.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.